title: Estimating the Lifetime Health Outcomes of Type 2 Diabetes Mellitus (T2dm) Patients Inadequately Controlled on Metformin Plus Sulphonylurea Receiving Either Canagliflozin or Sitagliptin Using the UKPDS Outcomes Model V1.3.
authors.affiliation: Janssen-Cilag A/S, Birkerød, Denmark.
authors.forename: S
authors.initials: S
authors.lastname: Nuhoho
authors.affiliation: Janssen-Cilag UK, High Wycombe, UK.
authors.forename: M
authors.initials: M
authors.lastname: Worbes-Cerezo